Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1557-1571
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1557
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1557
Table 1 Characteristics of the included studies
Ref. | Sample size (intensive/non-intensive statin) | Clinical presentation | Statin medication history | Primary/elective PCI | Statin regimen before PCI | Statin regimen after PCI | Follow-up (d) | Outcome indicators | |
Effectiveness | Safety | ||||||||
Liu et al[10], 2016 | 616 (307/309) | Stable angina, ACS | Statin-naïve or atorvastatin ≤ 20mg/d, or equivalent dose statin | Elective PCI | Atorvastatin 80 mg 12 h before PCI vs no statin pretreatment | 40 mg/d vs 20 mg/d | 30 | MACE, non-fatal MI | Myalgia/ |
182 (93/89) | STEMI | Statin-naïve or atorvastatin ≤ 20mg/d, or equivalent dose statin | Primary PCI | Atorvastatin 80 mg just before primary PCI vs no statin pretreatment | 40 mg/d vs 20 mg/d | 90 | ALT | ||
Jiao et al[11], 2015 | 72 (33/39) | NSTE-ACS | Not mentioned | Elective PCI | Rosuvastatin 20 mg 12 h before PCI + 20 mg just before PCI vs no statin pretreatment | 10 mg/d | 30 | MACE, cardiac death, non-fatal MI, TVR | |
Jiao et al[12], 2015 | 126 (62/64) | NSTE-ACS | Not mentioned | Elective PCI | Rosuvastatin 20 mg 12 h before PCI + 20 mg just before PCI vs no statin pretreatment | 10 mg/d | 30 | Myalgia/myasthenia | |
Zheng et al[7], 2015 | 1202 (573/629) | Stable angina, NSTE-ACS | Statin-naïve or atorvastatin ≤ 20mg/d or equivalent dose statin | Elective PCI | Atorvastatin 80 mg at night before PCI for 2 d vs atorvastatin ≤ 20 mg or equivalent dose statin at night before PCI | 40 mg/d vs ≤ 20 mg/d or equivalent dose statin | 30 | MACE, cardiac death, non-fatal MI, TVR | |
Xie et al[13], 2014 | 159 (79/80) | NSTE-ACS | Statin-naïve | Elective PCI | Rosuvastatin 20 mg 12 h before PCI + 20 mg 2 h before PCI vs no statin pretreatment | 10 mg/d | 30 | MACE, cardiac death, non-fatal MI, TVR | |
Luo et al[14], 2013 | 67 (31/36) | NSTE-ACS | Statin-naïve | Elective PCI | Rosuvastatin 20 mg 12 h before PCI + 20 mg 2 h before PCI vs no statin pretreatment | 10 mg/d | 30 | MACE, cardiac death, non-fatal MI, TVR | |
Wang et al[15], 2013 | 125 (62/63) | NSTE-ACS | Statin-naïve | Elective PCI | Rosuvastatin 20 mg 2-4 h before PCI vs placebo 2-4 h before PCI | 10 mg/d | 30 | MACE, cardiac death, non-fatal MI, TVR | |
Li et al[16], 2013 | 215 (106/109) | Stable angina | Regular statin for at least 3 mo | Elective PCI | Atorvastatin 80 mg 12 h before PCI vs 20 mg 12 h before PCI | 20 mg/d | 30 | MACE, cardiac death, non-fatal MI, TVR | |
Gao et al[17], 2012 | 117 (59/58) | NSTE-ACS | Statin-naïve | Elective PCI | Rosuvastatin 20 mg 12 h before PCI + 10 mg 2 h before PCI vs placebo 12 h before PCI + 2 h before PCI | 10 mg/d | 90 | MACE, cardiac death, non-fatal MI, TVR | |
Li et al[18], 2012 | 161 (78/83) | STEMI | Statin-naïve | Primary PCI | Atorvastatin 80 mg 1.5 h before PCI vs placebo 1.5 h before PCI | 40 mg/d | 30 | ALT | |
Yu et al[19], 2011 | 81 (41/40) | NSTE-ACS | Statin-naïve | Elective PCI | Atorvastatin 80 mg 12 h before PCI + 40 mg 2 h before PCI vs placebo 12 h before PCI + 2 h before PCI | 20 mg/d | 30 | MACE, cardiac death, non-fatal MI, TVR |
- Citation: Yang X, Lan X, Zhang XL, Han ZL, Yan SM, Wang WX, Xu B, Ge WH. Intensive vs non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: A meta-analysis of randomized controlled trials. World J Clin Cases 2022; 10(5): 1557-1571
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1557.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1557